Corixa corixa.com


Public list: Smart Money VCs (6328) Pharma Startups (4732) Cancer Therapeutics (1137)

Corixa is a biopharmaceutical company that develops oncology and immunology products that manage human diseases. The company is focused on immunotherapeutic products and has a broad technology platform enabling both fully integrated vaccine design and the use of its separate, proprietary product components on a standalone basis. Corixa previously traded on the Nasdaq Stock Market under the ticker CRXA.

Corixa is a biopharmaceutical company that develops oncology and immunology products that manage human diseases. The company is focused on immunotherapeutic products and has a broad technology platform enabling both fully integrated vaccine design an...Show all

Company (Acquired)

Phone: 206-366-3700

Fax:

1900 9th Avenue
Suite 1100
Seattle, 98101
Washington, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Corixa $471.2M May 20, 2010
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Corixa Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors

Board Members

Competitors

Company Status Description Investors

ARCA Biopharma

Broomfield, Colorado, United States
IPO / Went publicARCA biopharma, Inc. is a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases. ARCA began operations in 2005 and is headquartered in Denver, Colorado.Login to see details

Intarcia Therapeutics

Boston, Massachusetts, United States
Alive / ActiveIntarcia Therapeutics is a biopharmaceutical company developing therapies to ensure the best treatment outcome by optimizing patient convenience and adherence. Intarcia is addressing challenging diseases that require long-term chronic therapy by enhancing efficacy and reducing the burden therapies often place on the patient's life. Intarcia's drug development expertise and competitive edge is demonstrated by its ability to stabilize macromolecules and to deliver them in a constant and consistent...Show allLogin to see details
See all 16 competitors